Targeting Tumor Hypoxia with Potent Vascular Disrupting Agents

dc.contributor.advisorPinney, Kevin G.
dc.contributor.authorKuch, Bunnarack
dc.contributor.departmentBiochemistry.en_US
dc.contributor.otherBaylor University.en_US
dc.contributor.otherOXiGENE, Inc.en_US
dc.contributor.schoolsHonors College.en_US
dc.date.accessioned2016-08-09T18:20:51Z
dc.date.available2016-08-09T18:20:51Z
dc.date.copyright2016
dc.date.issued2016-08-09
dc.description.abstractCurrent therapeutic methods highlight the use of vascular disrupting agents (VDAs) in anti-cancer therapy. Through a binding interaction with the colchicine binding site on beta-tubulin, VDAs function as inhibitors of tubulin polymerization, resulting in morphological changes to the endothelial cells lining tumor-feeding vessels, which selectively disrupts blood flow to tumors and results in tumor necrosis. An active area of research inquiry centers on methods to further enhance selectivity of therapeutic agents and strategies towards tumors and targets within the tumor microenvironment, including vasculature. Bioreductively activatable prodrug conjugates (BAPCs) represent one such strategy. BAPCs utilize potent anti-cancer agents as prodrugs to selectively target tumor hypoxia. In order to reduce toxicity and enhance targeting, VDAs are coupled with bioreductive triggers to mask the ability of the resultant BAPCs to interact with the tubulin-microtubule protein system. Under hypoxic conditions which are inherent to many solid tumor cancers, the trigger compounds are cleaved, thus releasing the cytotoxic VDAs site-specific to the tumor. Synthetic pathways for these BAPCs have been developed to effectively couple highly active VDAs with bioreductive triggers.en_US
dc.identifier.urihttp://hdl.handle.net/2104/9727
dc.language.isoen_USen_US
dc.rightsBaylor University projects are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Contact libraryquestions@baylor.edu for inquiries about permission.en_US
dc.rights.accessrightsWorldwide access.en_US
dc.rights.accessrightsAccess changed 7/11/18.
dc.subjectOrganic chemistry.en_US
dc.titleTargeting Tumor Hypoxia with Potent Vascular Disrupting Agentsen_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Bunnarack Kuch Honors Thesis FINAL READY FOR PRINT FINAL.pdf
Size:
6.48 MB
Format:
Adobe Portable Document Format
Description:
Thesis
No Thumbnail Available
Name:
AuthorizationAgreementForm.pdf
Size:
1.78 MB
Format:
Adobe Portable Document Format
Description:
Authorization/Agreement Form